Bridgewater Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Bridgewater Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$318K	Sell	26,313 -11,091	-30%	-$150K	0.02%	364
2026 Q1	$486K	Buy	37,404 +4,164	+13%	+$58K	0.03%	258
2025 Q4	$441K	Sell	33,240 -1,004	-3%	-$14.1K	0.03%	285
2025 Q3	$461K	Sell	34,244 -1,388	-4%	-$20K	0.03%	263
2025 Q2	$526K	Buy	35,632 +3,659	+11%	+$52.3K	0.04%	238
2025 Q1	$446K	Buy	31,973 +880	+3%	+$12.1K	0.04%	246
2024 Q4	$474K	Buy	+31,093	New	+$467K	0.05%	115

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bridgewater Advisors's RDY Position: Q2 2026 in Review

Bridgewater Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 30% in Q2 2026, selling an estimated $150K and leaving 26,313 shares worth $318K. The position accounts for 0.02% of the portfolio, ranked #364.

Bridgewater Advisors first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. The position peaked at $526K in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Bridgewater Advisors held 26,313 shares of Dr. Reddy's Laboratories worth $318K as of Q2 2026.
Bridgewater Advisors sold 11,091 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $150K.
Dr. Reddy's Laboratories made up 0.02% of Bridgewater Advisors's portfolio in Q2 2026, its #364 holding.
Bridgewater Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
Bridgewater Advisors's Dr. Reddy's Laboratories position peaked at $526K in Q2 2025.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.